Who is the LEUKEMIA & LYMPHOMA SOCIETY?
The Leukemia & Lymphoma Society is a global leader dedicated to curing leukemia, lymphoma, myeloma, and other blood cancers. Since its founding, the Leukemia and Lymphoma Society has invested nearly $1.5 billion in groundbreaking research, provided free information and support services, and advocated for lifesaving treatments.
What is their mission?
The Leukemia & Lymphoma Society's mission is to cure leukemia, lymphoma, Hodgkin's disease, and myeloma, and to improve the quality of life for patients and their families. They achieve this through research, patient support, education, and advocacy.
What is their impact?
- Over $1.5 billion invested in cancer research
- Support services provided to thousands of patients annually
- Advocacy efforts leading to approval of nearly all new blood cancer therapies in the last decade
- Lifesaving treatments and innovative clinical trials improving patient outcomes
Why the LEUKEMIA & LYMPHOMA SOCIETY?
We believe that curing blood cancers is within reach, and everyone should have access to the best possible care and support. The Leukemia & Lymphoma Society provides essential research funding, patient services, educational resources, and advocacy efforts that save lives and improve the well-being of patients and their families
For more information, visit LLS.org
